FDA Decision on Genentech's Avastin Could Set New Standard for Cancer Drug Approvals (Canadian Business)
Matthew Perrone February 21, 2008 - 12:42 a.m. WASHINGTON (AP) - A decision expected Friday on federal approval for Genentech's Avastin cancer drug could have ramifications for all companies developing cancer medicines.

Cancer drug developers have eyes on FDA (Sun-Sentinel)
Measures of effectiveness under debate A decision expected today on federal approval for Genentech 's Avastin cancer drug could have ramifications for all companies developing cancer medicines.